{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:10:19Z","timestamp":1788801019996,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02387-5","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:21:17Z","timestamp":1782750077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term intake of statins or renin-angiotensin system inhibitors: associations with sarcopenia-related parameters in older people"],"prefix":"10.1007","author":[{"given":"Tansu M. I.","family":"Aydo\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Toepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Spira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4340-2523","authenticated-orcid":false,"given":"Ilja","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"1","key":"2387_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331.","journal-title":"Age Ageing"},{"issue":"4","key":"2387_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249\u201356.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"2387_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547\u201358.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2387_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae052","author":"B Kirk","year":"2024","unstructured":"Kirk B, Cawthon PM, Arai H, \u00c1vila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024. https:\/\/doi.org\/10.1093\/ageing\/afae052.","journal-title":"Age Ageing"},{"issue":"7","key":"2387_CR5","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/jgs.16372","volume":"68","author":"S Bhasin","year":"2020","unstructured":"Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020;68(7):1410\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2387_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.14283\/jfa.2019.10","volume":"8","author":"S Goates","year":"2019","unstructured":"Goates S, Du K, Arensberg MB, Gaillard T, Guralnik J, Pereira SL. Economic impact of hospitalizations in US adults with sarcopenia. J Frailty Aging. 2019;8(2):93\u20139.","journal-title":"J Frailty Aging"},{"issue":"2","key":"2387_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/jcsm.12934","volume":"13","author":"M Achison","year":"2022","unstructured":"Achison M, Adamson S, Akpan A, Aspray T, Avenell A, Band MM, et al. Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial. J Cachexia Sarcopenia Muscle. 2022;13(2):858\u201371.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"2387_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2019","unstructured":"Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2019;21(3):300-7.e2.","journal-title":"J Am Med Dir Assoc"},{"key":"2387_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155597","volume":"149","author":"Y Rolland","year":"2023","unstructured":"Rolland Y, Dray C, Vellas B, Barreto PS. Current and investigational medications for the treatment of sarcopenia. Metabolism. 2023;149:155597.","journal-title":"Metabolism"},{"key":"2387_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/2333721420920398","volume":"6","author":"L Dismore","year":"2020","unstructured":"Dismore L, Hurst C, Sayer AA, Stevenson E, Aspray T, Granic A. Study of the older adults\u2019 motivators and barriers engaging in a nutrition and resistance exercise intervention for sarcopenia: an embedded qualitative project in the MIlkMAN pilot study. Gerontol Geriatr Med. 2020;6:2333721420920398.","journal-title":"Gerontol Geriatr Med"},{"issue":"9","key":"2387_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/jch.14714","volume":"25","author":"Y Quan","year":"2023","unstructured":"Quan Y, Wang C, Wang L, Li G. Geriatric sarcopenia is associated with hypertension: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2023;25(9):808\u201316.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2387_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101264","volume":"44","author":"K Gao","year":"2022","unstructured":"Gao K, Cao LF, Ma WZ, Gao YJ, Luo MS, Zhu J, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. EClinicalMedicine. 2022;44:101264.","journal-title":"EClinicalMedicine"},{"issue":"34","key":"2387_CR13","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","volume":"43","author":"I Byty\u00e7i","year":"2022","unstructured":"Byty\u00e7i I, Penson PE, Mikhailidis DP, Wong ND, Hernandez AV, Sahebkar A, et al. Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43(34):3213\u201323.","journal-title":"Eur Heart J"},{"issue":"1","key":"2387_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14740338.2017.1238898","volume":"16","author":"EA Algharably","year":"2017","unstructured":"Algharably EA, Filler I, Rosenfeld S, Grabowski K, Kreutz R. Statin intolerance - a question of definition. Expert Opin Drug Saf. 2017;16(1):55\u201363.","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"2387_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/qjmed\/hcp093","volume":"102","author":"D Scott","year":"2009","unstructured":"Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM. 2009;102(9):625\u201333.","journal-title":"QJM"},{"issue":"10","key":"2387_CR16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/gerona\/62.10.1164","volume":"62","author":"SE Riechman","year":"2007","unstructured":"Riechman SE, Andrews RD, Maclean DA, Sheather S. Statins and dietary and serum cholesterol are associated with increased lean mass following resistance training. J Gerontol A Biol Sci Med Sci. 2007;62(10):1164\u201371.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2387_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17051494","author":"MH Lin","year":"2020","unstructured":"Lin MH, Chiu SY, Chang PH, Lai YL, Chen PC, Ho WC. Hyperlipidemia and statins use for the risk of new diagnosed sarcopenia in patients with chronic kidney: a population-based study. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17051494.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2387_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13660","volume":"16","author":"ST Huang","year":"2025","unstructured":"Huang ST, Otsuka R, Nishita Y, Meng LC, Hsiao FY, Shimokata H, et al. Risk of sarcopenia following long-term statin use in community-dwelling middle-aged and older adults in Japan. J Cachexia Sarcopenia Muscle. 2025;16(1):e13660.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"2387_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/ageing\/afu008","volume":"43","author":"MD Witham","year":"2014","unstructured":"Witham MD, Syddall HE, Dennison E, Cooper C, McMurdo ME, Sayer AA. ACE inhibitors, statins and thiazides: no association with change in grip strength among community dwelling older men and women from the Hertfordshire Cohort Study. Age Ageing. 2014;43(5):661\u20136.","journal-title":"Age Ageing"},{"issue":"11","key":"2387_CR20","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/gerona\/glw057","volume":"71","author":"RM Henderson","year":"2016","unstructured":"Henderson RM, Lovato L, Miller ME, Fielding RA, Church TS, Newman AB, et al. Effect of statin use on mobility disability and its prevention in at-risk older adults: the LIFE study. J Gerontol A Biol Sci Med Sci. 2016;71(11):1519\u201324.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2387_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","volume":"127","author":"BA Parker","year":"2013","unstructured":"Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, et al. Effect of statins on skeletal muscle function. Circ. 2013;127(1):96\u2013103.","journal-title":"Circ"},{"key":"2387_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.12.020","author":"W Zeng","year":"2024","unstructured":"Zeng W, Deng H, Luo Y, Zhong S, Huang M, Tomlinson B. Advances in statin adverse reactions and the potential mechanisms: a systematic review. J Adv Res. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.12.020.","journal-title":"J Adv Res"},{"issue":"11","key":"2387_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-016-0396-8","volume":"33","author":"D Spira","year":"2016","unstructured":"Spira D, Walston J, Buchmann N, Nikolov J, Demuth I, Steinhagen-Thiessen E, et al. Angiotensin-converting enzyme inhibitors and parameters of sarcopenia: relation to muscle mass, strength and function: data from the Berlin Aging Study-II (BASE-II). Drugs Aging. 2016;33(11):829\u201337.","journal-title":"Drugs Aging"},{"issue":"6","key":"2387_CR24","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/j.1532-5415.2004.52265.x","volume":"52","author":"M Di Bari","year":"2004","unstructured":"Di Bari M, van de Poll-Franse LV, Onder G, Kritchevsky SB, Newman A, Harris TB, et al. Antihypertensive medications and differences in muscle mass in older persons: the health, aging and body composition study. J Am Geriatr Soc. 2004;52(6):961\u20136.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2387_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/PHM.0000000000002045","volume":"102","author":"M Kara","year":"2023","unstructured":"Kara M, Kara \u00d6, Ceran Y, Kaymak B, Kaya TC, \u00c7\u0131t\u0131r BN, et al. SARcopenia assessment in hypertension: the SARAH study. Am J Phys Med Rehabil. 2023;102(2):130\u20136.","journal-title":"Am J Phys Med Rehabil"},{"issue":"10","key":"2387_CR26","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/j.1532-5415.2011.03610_12.x","volume":"59","author":"T Pozos-L\u00f3pez","year":"2011","unstructured":"Pozos-L\u00f3pez T, Navarrete-Reyes AP, \u00c1vila-Funes JA. Is frailty associated with cardiovascular drug use? J Am Geriatr Soc. 2011;59(10):1977\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"2387_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2023.102890","volume":"54","author":"R Qaisar","year":"2023","unstructured":"Qaisar R, Kamli H, Karim A, Muhammad T, Ahmad F, Shaikh A. Angiotensin receptor blockers restore skeletal muscle in patients with chronic obstructive pulmonary disease. Arch Med Res. 2023;54(7):102890.","journal-title":"Arch Med Res"},{"issue":"10","key":"2387_CR28","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/gerona\/gly277","volume":"74","author":"M Pahor","year":"2019","unstructured":"Pahor M, Anton SD, Beavers DP, Cauley JA, Fielding RA, Kritchevsky SB, et al. Effect of losartan and fish oil on plasma IL-6 and mobility in older persons. The ENRGISE pilot randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2019;74(10):1612\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"2387_CR29","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jamda.2020.07.012","volume":"22","author":"L Caulfield","year":"2021","unstructured":"Caulfield L, Heslop P, Walesby KE, Sumukadas D, Sayer AA, Witham MD. Effect of angiotensin system inhibitors on physical performance in older people - a systematic review and meta-analysis. J Am Med Dir Assoc. 2021;22(6):1215-21.e2.","journal-title":"J Am Med Dir Assoc"},{"issue":"24","key":"2387_CR30","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1042\/CS20220501","volume":"138","author":"H Takeshita","year":"2024","unstructured":"Takeshita H, Yamamoto K, Mogi M, Rakugi H. Muscle mass, muscle strength and the renin-angiotensin system. Clin Sci (Lond). 2024;138(24):1561\u201377.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"2387_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2023.101523","volume":"36","author":"RP Gale","year":"2023","unstructured":"Gale RP, Zhang MJ, Lazarus HM. The role of randomized controlled trials, registries, observational databases in evaluating new interventions. Best Pract Res Clin Haematol. 2023;36(4):101523.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"2387_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/ije\/dyt018","volume":"43","author":"L Bertram","year":"2014","unstructured":"Bertram L, Bockenhoff A, Demuth I, Duzel S, Eckardt R, Li SC, et al. Cohort profile: the Berlin Aging Study II (BASE-II). Int J Epidemiol. 2014;43(3):703\u201312.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"2387_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045576","volume":"11","author":"I Demuth","year":"2021","unstructured":"Demuth I, Banszerus V, Drewelies J, D\u00fczel S, Seeland U, Spira D, et al. Cohort profile: follow-up of a Berlin Aging Study II (BASE-II) subsample as part of the GendAge study. BMJ Open. 2021;11(6):e045576.","journal-title":"BMJ Open"},{"issue":"3","key":"2387_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000441495","volume":"62","author":"D Gerstorf","year":"2016","unstructured":"Gerstorf D, Bertram L, Lindenberger U, Pawelec G, Demuth I, Steinhagen-Thiessen E, et al. Editorial. Gerontology. 2016;62(3):311\u20135.","journal-title":"Gerontology"},{"issue":"1","key":"2387_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/gerona\/glx074","volume":"73","author":"M Konig","year":"2017","unstructured":"Konig M, Spira D, Demuth I, Steinhagen-Thiessen E, Norman K. Polypharmacy as a risk factor for clinically relevant sarcopenia: results from the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci. 2017;73(1):117\u201322.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"2387_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/gerona\/glu023","volume":"69","author":"PM Cawthon","year":"2014","unstructured":"Cawthon PM, Peters KW, Shardell MD, McLean RR, Dam TT, Kenny AM, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69(5):567\u201375.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"2387_CR37","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/gerona\/glu012","volume":"69","author":"RR McLean","year":"2014","unstructured":"McLean RR, Shardell MD, Alley DE, Cawthon PM, Fragala MS, Harris TB, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 2014;69(5):576\u201383.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2387_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S. The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2387_CR39","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"2387_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1532-5415.2003.51105.x","volume":"51","author":"AB Newman","year":"2003","unstructured":"Newman AB, Haggerty CL, Goodpaster B, Harris T, Kritchevsky S, Nevitt M, et al. Strength and muscle quality in a well-functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2003;51(3):323\u201330.","journal-title":"J Am Geriatr Soc"},{"key":"2387_CR41","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61\u20135.","journal-title":"Md State Med J"},{"issue":"1","key":"2387_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36924-5","volume":"13","author":"VM Vetter","year":"2023","unstructured":"Vetter VM, Ozince DD, Kiselev J, Duzel S, Demuth I. Self-reported and accelerometer-based assessment of physical activity in older adults: results from the Berlin Aging Study II. Sci Rep. 2023;13(1):10047.","journal-title":"Sci Rep"},{"issue":"6","key":"2387_CR43","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1159\/000518411","volume":"68","author":"S Toepfer","year":"2022","unstructured":"Toepfer S, K\u00f6nig M, Spira D, Drewelies J, Kreutz R, Bolbrinker J, et al. Sex differences in characteristics associated with potentially inappropriate medication use and associations with functional capacity in older participants of the Berlin Aging Study II. Gerontology. 2022;68(6):664\u201372.","journal-title":"Gerontology"},{"issue":"12","key":"2387_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226511","volume":"14","author":"S Toepfer","year":"2019","unstructured":"Toepfer S, Bolbrinker J, K\u00f6nig M, Steinhagen-Thiessen E, Kreutz R, Demuth I. Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) - sex differences and associations with morbidity and medication use. PLoS ONE. 2019;14(12):e0226511.","journal-title":"PLoS ONE"},{"issue":"5","key":"2387_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"1","key":"2387_CR46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3945\/ajcn.115.116806","volume":"103","author":"A Meyer","year":"2016","unstructured":"Meyer A, Salewsky B, Spira D, Steinhagen-Thiessen E, Norman K, Demuth I. Leukocyte telomere length is related to appendicular lean mass: cross-sectional data from the Berlin Aging Study II (BASE-II). Am J Clin Nutr. 2016;103(1):178\u201383.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"2387_CR47","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40266-018-0580-0","volume":"35","author":"M K\u00f6nig","year":"2018","unstructured":"K\u00f6nig M, Gollasch M, Rosada A, Demuth I, Spira D, Steinhagen-Thiessen E. Antihypertensive treatment patterns and blood pressure control in older adults: results from the Berlin Aging Study II. Drugs Aging. 2018;35(11):993\u20131003.","journal-title":"Drugs Aging"},{"issue":"8","key":"2387_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15104","volume":"40","author":"J Spieker","year":"2023","unstructured":"Spieker J, Vetter VM, Drewelies J, Spira D, Steinhagen-Thiessen E, Regitz-Zagrosek V, et al. Diabetes type 2 in the Berlin Aging Study II: cross-sectional and longitudinal data on prevalence, incidence and severity over on average seven years of follow-up. Diabet Med. 2023;40(8):e15104.","journal-title":"Diabet Med"},{"issue":"9","key":"2387_CR49","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2387_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s40520-025-02995-9","volume":"37","author":"C Beaudart","year":"2025","unstructured":"Beaudart C, Alcazar J, Aprahamian I, Batsis JA, Yamada Y, Prado CM, et al. Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS). Aging Clin Exp Res. 2025;37(1):100.","journal-title":"Aging Clin Exp Res"},{"key":"2387_CR51","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2023","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2023."},{"key":"2387_CR52","volume-title":"RStudio: integrated development for R","author":"RStudio Team","year":"2023","unstructured":"RStudio Team. RStudio: integrated development for R. Boston, MA: RStudio, PBC; 2023."},{"issue":"10355","key":"2387_CR53","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S0140-6736(22)01545-8","volume":"400","author":"CTT Collaboration","year":"2022","unstructured":"Collaboration CTT. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet. 2022;400(10355):832\u201345.","journal-title":"Lancet"},{"key":"2387_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2021.05.016","volume":"328","author":"JE Blais","year":"2021","unstructured":"Blais JE, Wei Y, Yap KKW, Alwafi H, Ma TT, Brauer R, et al. Trends in lipid-modifying agent use in 83 countries. Atherosclerosis. 2021;328:44\u201351.","journal-title":"Atherosclerosis"},{"issue":"38","key":"2387_CR55","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018.","journal-title":"Eur Heart J"},{"issue":"12","key":"2387_CR56","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension. J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"issue":"13","key":"2387_CR57","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jacc.2022.02.001","volume":"79","author":"I Fegers-Wustrow","year":"2022","unstructured":"Fegers-Wustrow I, Gianos E, Halle M, Yang E. Comparison of American and European guidelines for primary prevention of cardiovascular disease: JACC guideline comparison. J Am Coll Cardiol. 2022;79(13):1304\u201313.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2387_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1589\/jpts.28.547","volume":"28","author":"VA Coelho","year":"2016","unstructured":"Coelho VA, Probst VS, Nogari BM, Teixeira DC, Felcar JM, Santos DC, et al. Angiotensin-II blockage, muscle strength, and exercise capacity in physically independent older adults. J Phys Ther Sci. 2016;28(2):547\u201352.","journal-title":"J Phys Ther Sci"},{"key":"2387_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00564","volume":"11","author":"J Kalibala","year":"2020","unstructured":"Kalibala J, Pech\u00e8re-Bertschi A, Desmeules J. Gender differences in cardiovascular pharmacotherapy-the example of hypertension: a mini review. Front Pharmacol. 2020;11:564.","journal-title":"Front Pharmacol"},{"issue":"6","key":"2387_CR60","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/gerona\/glu246","volume":"70","author":"D Spira","year":"2015","unstructured":"Spira D, Buchmann N, Nikolov J, Demuth I, Steinhagen-Thiessen E, Eckardt R, et al. Association of low lean mass with frailty and physical performance: a comparison between two operational definitions of sarcopenia-data from the Berlin Aging Study II (BASE-II). J Gerontol A Biol Sci Med Sci. 2015;70(6):779\u201384.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9310","key":"2387_CR61","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","volume":"359","author":"G Onder","year":"2002","unstructured":"Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet. 2002;359(9310):926\u201330.","journal-title":"Lancet"},{"issue":"8","key":"2387_CR62","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1532-5415.2009.02366.x","volume":"57","author":"PM Cawthon","year":"2009","unstructured":"Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, et al. Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc. 2009;57(8):1411\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"2387_CR63","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/CM9.0000000000002193","volume":"135","author":"M Wu","year":"2022","unstructured":"Wu M, Wei Y, Lv J, Guo Y, Pei P, Li J, et al. Associations of muscle mass, strength, and quality with all-cause mortality in China: a population-based cohort study. Chin Med J (Engl). 2022;135(11):1358\u201368.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"2387_CR64","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1684\/mrh.2014.0352","volume":"26","author":"H Okazaki","year":"2013","unstructured":"Okazaki H, Ishimura E, Okuno S, Norimine K, Yamakawa K, Yamakawa T, et al. Significant positive relationship between serum magnesium and muscle quality in maintenance hemodialysis patients. Magnes Res. 2013;26(4):182\u20137.","journal-title":"Magnes Res"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02387-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:03:19Z","timestamp":1788800599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02387-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":64,"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02387-5","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RK reports received honoraria for consultancy and lectures from AstraZeneca, Bayer, Merck, Krka, Menarini Group, ProMed, PolPharma, Recor, Servier, and Zentiva. The other authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}